M7Q-32787-57314
3 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 359 / AL
- Registered
- 2022-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-14
Dose 1 — Moderna
-
2021-05-15
Dose 2 — Moderna
-
2022-01-19
Registered in v-safe
-
2022-01-19
Dose 3 — Moderna
-
2022-01-19
Survey response — day 0, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-01-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body achesAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Moderna | No |
| 2 | 2021-05-15 | Moderna | No |
| 3 | 2022-01-19 | Moderna | No |
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release